Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance Registry.

MLA

Ogawa, Satoshi, et al. “Present Profiles of Novel Anticoagulant Use in Japanese Patients with Atrial Fibrillation: Insights from the Rivaroxaban Postmarketing Surveillance Registry.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, vol. 23, no. 10, Nov. 2014, pp. 2520–26. EBSCOhost, https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.03.006.

APA

Ogawa, S., Ikeda, T., Kitazono, T., Nakagawara, J., Minematsu, K., Miyamoto, S., Murakawa, Y., Iekushi, K., Yamanaka, S., Yamada, T., & Inuyama, L. (2014). Present profiles of novel anticoagulant use in Japanese patients with atrial fibrillation: insights from the Rivaroxaban Postmarketing Surveillance Registry. Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, 23(10), 2520–2526. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.03.006

Chicago

Ogawa, Satoshi, Takanori Ikeda, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, et al. 2014. “Present Profiles of Novel Anticoagulant Use in Japanese Patients with Atrial Fibrillation: Insights from the Rivaroxaban Postmarketing Surveillance Registry.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association 23 (10): 2520–26. doi:10.1016/j.jstrokecerebrovasdis.2014.03.006.